Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schrauder

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia Research|December 17, 2008
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemiaH von Goessel, U Jacobs, S Semper, et al.
Leukemia|April 27, 2007
Childhood secondary ALL after ALL treatmentJ Zuna, H Cavé, C Eckert, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Leukemia|December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000A Möricke, M Zimmermann, A Reiter, et al.
Leukemia|February 3, 2007
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementM W J C Jansen, L Corral, V H J van der Velden, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Leukemia|February 9, 2007
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?G Mann, G Cazzaniga, V H J van der Velden, et al.
Leukemia Research|December 17, 2008
Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemiaH von Goessel, U Jacobs, S Semper, et al.
Leukemia|April 27, 2007
Childhood secondary ALL after ALL treatmentJ Zuna, H Cavé, C Eckert, et al.
Leukemia|February 9, 2007
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center settingV H J van der Velden, E R Panzer-Grümayer, G Cazzaniga, et al.
Leukemia|December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000A Möricke, M Zimmermann, A Reiter, et al.
Leukemia|February 3, 2007
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangementM W J C Jansen, L Corral, V H J van der Velden, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Leukemia|February 2, 2008
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemiaT Flohr, A Schrauder, G Cazzaniga, et al.
Leukemia|February 9, 2007
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.
Pageof 4